Drugs / hCG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07523022 | Sep 2024 → Sep 2026 overdue | male infertility | Szeged University | Enrolling by invitation | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | hCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07523022 ↗ |
| Route | Subcutaneous | “hCG 2x5000NE sc weekly for 12 weeks” NCT07523022 ↗ |